Real-time myoglobin saturation measurement to assess benefit of RBC transfusion

Ended Project Grant Awarded Last action

Award ID
R44HL127543
Recipient
Awarding agency
Obligated
$7,706,108

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Funding
  • $6,734,623.00 Federal
  • $971,485.00 Non-federal
Place of performance
Seattle, WA 98195, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $910,791 $0
Amendment $910,791 $0
Amendment $971,485 $0
Amendment $971,485 $0
Amendment $971,485 $971,485
Amendment $998,586 $0
Amendment Noninvasive compact device to monitor myoglobin saturation in anemia and critical illness $0 $0
Amendment $500,000 $0
Original award $500,000 $0

Quick answers

Who received award R44HL127543?

R44HL127543 was awarded to Opticyte Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on April 1, 2015.

How much is award R44HL127543 worth?

$7,706,108 has been obligated on R44HL127543: $6,734,623 in federal funding and $971,485 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award